Biofrontera (BFRIW) Asset Utilization Ratio (2021 - 2025)
Biofrontera (BFRIW) recorded quarterly Asset Utilization Ratio of 1.9 in Q4 2025, down 9.27% quarter-over-quarter from 2.09 in Q3 2025, and up 3.2% on a YoY basis from 1.84 in Q4 2024.
Biofrontera (BFRIW) Asset Utilization Ratio (2021 - 2025) Analysis & Trends
Biofrontera's Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 1.9 for Q4 2025.
- In Q4 2025, Asset Utilization Ratio rose 3.2% year-over-year to 1.9; the TTM figure through Dec 2025 stood at 1.9 (up 3.2% YoY), while the FY2025 annual figure was 1.65, up 10.35% from the prior year.
- Asset Utilization Ratio was 1.9 for Q4 2025 at Biofrontera, down from 2.09 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 2.13 in Q2 2025 to a low of 0.51 in Q3 2022.
- Historically, Asset Utilization Ratio has averaged 1.27 across 5 years, with a median of 1.27 in 2024.
- The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio fell 22.99% in 2022, then surged 112.61% in 2024.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.7 in 2021, then slipped by 22.99% to 0.54 in 2022, then jumped by 102.93% to 1.1 in 2023, then jumped by 67.3% to 1.84 in 2024, then increased by 3.2% to 1.9 in 2025.
- The last three Asset Utilization Ratio figures came in at 1.9 (Q4 2025), 2.09 (Q3 2025), and 2.13 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.43 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 0.62 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 0.43 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.48 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 0.65 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.37 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.36 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.07 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.68 |
| 10 | Biofrontera | - | - | 14.09 Mn | 1.90 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.90 |
| Sep 30, 2025 | 2.09 |
| Jun 30, 2025 | 2.13 |
| Mar 31, 2025 | 1.96 |
| Dec 31, 2024 | 1.84 |
| Sep 30, 2024 | 1.76 |
| Jun 30, 2024 | 1.53 |
| Mar 31, 2024 | 1.27 |
| Dec 31, 2023 | 1.10 |
| Mar 31, 2023 | 0.60 |
| Dec 31, 2022 | 0.54 |
| Sep 30, 2022 | 0.51 |
| Jun 30, 2022 | 0.54 |
| Mar 31, 2022 | 0.57 |
| Dec 31, 2021 | 0.70 |